Skip to main content
. 2024 Nov 8;12:1396832. doi: 10.3389/fpubh.2024.1396832

Figure 3.

Figure 3

Evolution of medication efficiency of T2D drugs. The computation was based on the RDM approach in (2) and employed dose frequency as input, HbA1c decrease and weight loss as desirable outputs, mortality rate as undesirable output. The year was the first approval year by FDA. The data for inputs and outputs were from meta-analysis published on flagship medical journals.